CG Oncology Inc. (CGON) vs Kodiak Sciences Inc. (KOD)
A side-by-side comparison of CG Oncology Inc. and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$63.64HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
KOD
Kodiak Sciences Inc.
$92.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CGON vs KOD
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)KOD +2498.6% (+196.2%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
CGON KOD
CGON vs KOD: by the numbers
- •KOD is the larger company ($5.78B vs $5.61B market cap).
- •Both run net losses; KOD's is the smaller (0.00% vs -3602.68% net margin).
Metrics side by side
Valuation
| Metric | CGON | KOD |
|---|---|---|
| P/S ratio | 901.29 | N/A |
| P/B ratio | 5.45 | 94.58 |
Profitability
| Metric | CGON | KOD |
|---|---|---|
| Gross margin | -15.02% | 0.00% |
| Operating margin | -4722.13% | 0.00% |
| Net margin | -3602.68% | 0.00% |
| ROE | -21.80% | -396.09% |
| ROIC | -24.33% | -115.23% |
Growth (annualized)
| Metric | CGON | KOD |
|---|---|---|
| Total return CAGR (5Y) | N/A | 36.19% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.